Clinical Trial Update: Risedronate in Osteopenic Postmenopausal Women [Phase 3]

View source ↗

Summary

Sanofi-sponsored Phase 3 trial update on risedronate in osteopenic postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED